AstraZeneca-Amgen Tezspire gets USFDA nod for chronic rhinosinusitis with nasal polyps
- 18 October 2025
- 5 days ago
Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US
- 01 October 2025
- 3 weeks ago
Amgen announces USD 650 million expansion of US manufacturing network
- 30 September 2025
- 3 weeks ago
AstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal polyps
- 22 September 2025
- 1 month ago
Glenmark Pharma Bags USFDA Nod For Generic Version Of Otezla Tablets
- 01 August 2025
- 2 months ago
Recent News
Early life sugar restriction linked to lasting hea...
- 23 October, 2025
Air Pollution May Slow Infant Brain Development: S...
- 23 October, 2025
AI Outperforms Traditional Tools in Predicting Hea...
- 23 October, 2025
Nearly Half of Acute Pancreatitis Patients Develop...
- 23 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.